Lantheus Holdings (LNTH) Assets Average (2015 - 2026)
Lantheus Holdings' (LNTH) quarterly Assets Average came in at $2.3 billion in Q1 2026, up 13.34% year-on-year from $2.0 billion in Q1 2025, and up 1.56% on a QoQ basis from $2.3 billion in Q4 2025.
Lantheus Holdings (LNTH) Assets Average (2015 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 12 years of Assets Average data on file, last reported at $2.3 billion in Q1 2026.
- On a quarterly basis, Assets Average rose 13.34% year-over-year to $2.3 billion in Q1 2026; TTM through Mar 2026 was $2.3 billion, a 13.34% increase from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 15.87% from the prior year.
- Assets Average for Q1 2026 stood at $2.3 billion, up from $2.3 billion in the prior quarter.
- Over the last five years, Assets Average for LNTH reached as high as $2.3 billion in Q1 2026 and fell as low as $898.5 million in Q1 2022.
- Historically, Assets Average has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2024.
- Across the five-year window, Assets Average rose 4.88% in 2022 and soared 48.62% in 2023, its largest moves.
- Year by year, Assets Average stood at $1.2 billion in 2022, then soared by 31.26% to $1.6 billion in 2023, then advanced by 27.02% to $2.0 billion in 2024, then advanced by 11.76% to $2.3 billion in 2025, then climbed by 1.56% to $2.3 billion in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $2.3 billion in Q1 2026, $2.3 billion in Q4 2025, and $2.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 2.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.29 Bn |
| Dec 31, 2025 | 2.25 Bn |
| Sep 30, 2025 | 2.20 Bn |
| Jun 30, 2025 | 2.09 Bn |
| Mar 31, 2025 | 2.02 Bn |
| Dec 31, 2024 | 2.01 Bn |
| Sep 30, 2024 | 1.99 Bn |
| Jun 30, 2024 | 1.89 Bn |
| Mar 31, 2024 | 1.74 Bn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.43 Bn |
| Jun 30, 2023 | 1.34 Bn |
| Mar 31, 2023 | 1.34 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.05 Bn |
| Jun 30, 2022 | 973.50 Mn |
| Mar 31, 2022 | 898.48 Mn |
| Dec 31, 2021 | 855.80 Mn |
| Sep 30, 2021 | 852.81 Mn |
| Jun 30, 2021 | 850.63 Mn |